Related Experiment Video
Updated: Jul 7, 2026
10:44
Generating Whole Bacterial Genomes from Clinical Samples using a Target Enrichment Workflow
Published on: August 15, 2025
Antigenic profiling of a Chlamydia trachomatis gene-expression library.
Frank Follmann1, Anja Weinreich Olsen, Klaus Thorleif Jensen
1Chlamydia Research, Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark.
The Journal of Infectious Diseases
|February 22, 2008
Summary
Researchers identified key immune targets in Chlamydia trachomatis, including T cell and B cell antigens. These findings are crucial for developing a new chlamydia vaccine to combat sexually transmitted infections.
Area of Science:
- Immunology
- Microbiology
- Vaccinology
Background:
- Chlamydia trachomatis is a bacterium causing sexually transmitted infections.
- Understanding immune responses is vital for vaccine development.
Purpose of the Study:
- To characterize cell-mediated and humoral immune responses to C. trachomatis antigens.
- To identify potential vaccine candidates against chlamydia infections.
Main Methods:
- Evaluated 116 recombinant C. trachomatis proteins.
- Assessed immune recognition by T cells and B cells in infected patients.
- Correlated antigen recognition with predicted cellular localization.
Main Results:
- Identified 5 T cell antigens (CT004, CT043, CT184, CT509, CT611).
- Identified 5 B cell antigens (CT082, CT089, CT322, CT396, CT681).
- Identified 2 T/B cell antigens (CT110, CT443).
- Antibody targets are primarily in the outer membrane; T cell targets are in all compartments.
Conclusions:
- Five T cell, five B cell, and two T/B cell antigens were identified as potential chlamydia vaccine components.
- Antigen localization provides insights into immune response mechanisms.
